Far East Consortium International Ltd
F:FET
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Far East Consortium International Ltd
F:FET
|
KY |
|
N
|
Neogen Corp
F:NG2
|
US |
|
B
|
Bio Green Energy Tech PCL
SET:BIOTEC
|
TH |
|
Ovation Science Inc
F:0VH
|
CA |
|
Gunanusa Eramandiri Tbk PT
IDX:GUNA
|
ID |
|
F
|
Finansia X PCL
SET:FSX
|
TH |
|
T
|
TWZ Corporation PCL
SET:TWZ
|
TH |
Earnings Calls
Last Earnings Call
Adjusted Revenue: Adjusted revenue reached HKD 4.9 billion, mainly from property development project completions in the UK and Australia.
Profitability: Adjusted cash profit was HKD 203 million, but the company reported a net loss of HKD 988 million due to large non-cash impairment charges.
Gross Margin: Adjusted gross profit margin increased by 3.6 percentage points, with overall gross margin at 34.8%, mainly driven by higher-margin property sales.
Hotel Growth: Hotel revenue rose 9.5% to hit almost HKD 1 billion, helped by new hotel openings and improving occupancy and room rates, especially in Hong Kong.
Debt Reduction: Net gearing ratio fell to 64.9%, down about 2.7 points versus March, as the company paid down over HKD 1.2 billion in debt.
Presales Pipeline: Presales and contracted sales stand at HKD 9.3 billion, giving strong visibility for future revenue.
Asset Sales: About HKD 1 billion of noncore assets were monetized, including mortgage portfolios and car parks; more disposals are planned.
Project Pipeline: A robust HKD 62 billion property development pipeline is supporting growth and future cash flow.